News
Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...
The demand for the widely used cancer drug paclitaxel is increasing, but it’s difficult and expensive to produce because it ...
2don MSN
Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...
New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...
Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...
Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...
Xoted Biotechnology Labs opens in Duncan’s Spark Center, bringing biotech innovation, R&D, and sustainable manufacturing to ...
The committee on Monday awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results